CCT241736 is primarily used in research settings as a potent and selective inhibitor of the enzyme PLK4 (Polo-like kinase 4). It is particularly valuable in studying the role of PLK4 in cell division, especially centriole duplication, which is critical for maintaining genomic stability. Researchers utilize this compound to explore its potential in disrupting cancer cell proliferation, as PLK4 is often overexpressed in various cancers. Additionally, CCT241736 aids in understanding the mechanisms of centriole amplification and its implications in tumorigenesis, providing insights for developing targeted cancer therapies. Its application extends to preclinical studies aimed at evaluating its efficacy and safety as a potential anticancer agent.